Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1) - PubMed (original) (raw)
Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1)
M S Diamond et al. J Cell Biol. 1995 Sep.
Abstract
Previous studies have demonstrated that the leukocyte integrin Mac-1 adheres to several cell surface and soluble ligands including intercellular adhesion molecule-1, fibrinogen, iC3b, and factor X. However, experiments with Mac-1-expressing transfectants, purified Mac-1, and mAbs to Mac-1 indicate the existence of additional ligands. In this paper, we demonstrate a direct interaction between Mac-1 and heparan sulfate glycans. Heparin affinity resins immunoprecipitate Mac-1, and neutrophils and transfectant cells that express Mac-1 bind to heparin and heparan sulfate, but not to other sulfated glycosaminoglycans. Inhibition studies with mAbs and chemically modified forms of heparin suggest the I domain as a recognition site on Mac-1 for heparin, and suggest that either N- or O-sulfation is sufficient for heparin to bind efficiently to Mac-1. Under conditions of continuous flow in which heparins and E-selectin are cosubstrates, neutrophils tether to E-selectin and form firm adhesions through a Mac-1-heparin interaction.
Similar articles
- Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18).
Peter K, Schwarz M, Conradt C, Nordt T, Moser M, Kübler W, Bode C. Peter K, et al. Circulation. 1999 Oct 5;100(14):1533-9. doi: 10.1161/01.cir.100.14.1533. Circulation. 1999. PMID: 10510057 - Promotion of leukocyte adhesion by a novel interaction between vitronectin and the beta2 integrin Mac-1 (alphaMbeta2, CD11b/CD18).
Kanse SM, Matz RL, Preissner KT, Peter K. Kanse SM, et al. Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2251-6. doi: 10.1161/01.ATV.0000146529.68729.8b. Epub 2004 Sep 30. Arterioscler Thromb Vasc Biol. 2004. PMID: 15458976 - Heterogenous glycosylation of ICAM-3 and lack of interaction with Mac-1 and p150,95.
de Fougerolles AR, Diamond MS, Springer TA. de Fougerolles AR, et al. Eur J Immunol. 1995 Apr;25(4):1008-12. doi: 10.1002/eji.1830250422. Eur J Immunol. 1995. PMID: 7737271 - ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18).
Diamond MS, Staunton DE, de Fougerolles AR, Stacker SA, Garcia-Aguilar J, Hibbs ML, Springer TA. Diamond MS, et al. J Cell Biol. 1990 Dec;111(6 Pt 2):3129-39. doi: 10.1083/jcb.111.6.3129. J Cell Biol. 1990. PMID: 1980124 Free PMC article. - Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions.
Weber C, Erl W, Weber KS, Weber PC. Weber C, et al. Clin Chem Lab Med. 1999 Mar;37(3):243-51. doi: 10.1515/CCLM.1999.043. Clin Chem Lab Med. 1999. PMID: 10353467 Review.
Cited by
- Host-microbe interaction paradigms in acute and recurrent vulvovaginal candidiasis.
MacAlpine J, Lionakis MS. MacAlpine J, et al. Cell Host Microbe. 2024 Oct 9;32(10):1654-1667. doi: 10.1016/j.chom.2024.08.018. Cell Host Microbe. 2024. PMID: 39389030 Review. - "Two-birds-one-stone" oral nanotherapeutic designed to target intestinal integrins and regulate redox homeostasis for UC treatment.
Huang L, Hu W, Huang LQ, Zhou QX, Song ZY, Tao HY, Xu B, Zhang CY, Wang Y, Xing XH. Huang L, et al. Sci Adv. 2024 Jul 26;10(30):eado7438. doi: 10.1126/sciadv.ado7438. Epub 2024 Jul 24. Sci Adv. 2024. PMID: 39047093 Free PMC article. - VSIG4 interaction with heparan sulfates inhibits VSIG4-complement binding.
Ebstein SY, Rafique A, Zhou Y, Krasco A, Montalvo-Ortiz W, Yu L, Custodio L, Adam RC, Bloch N, Lee K, Adewale F, Vergata D, Luz A, Coquery S, Daniel B, Ullman E, Franklin MC, Hermann A, Huang T, Olson W, Davis S, Murphy AJ, Sleeman MA, Wei J, Skokos D. Ebstein SY, et al. Glycobiology. 2023 Aug 14;33(7):591-604. doi: 10.1093/glycob/cwad050. Glycobiology. 2023. PMID: 37341346 Free PMC article. - Glomerular endothelial glycocalyx-derived heparan sulfate inhibits glomerular leukocyte influx and attenuates experimental glomerulonephritis.
Maciej-Hulme ML, Van Gemst JJ, Sanderson P, Rops ALWMM, Berden JH, Smeets B, Amster IJ, Rabelink TJ, Van Der Vlag J. Maciej-Hulme ML, et al. Front Mol Biosci. 2023 Jun 1;10:1177560. doi: 10.3389/fmolb.2023.1177560. eCollection 2023. Front Mol Biosci. 2023. PMID: 37325479 Free PMC article. - Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease.
Shute JK. Shute JK. Pharmaceuticals (Basel). 2023 Apr 13;16(4):584. doi: 10.3390/ph16040584. Pharmaceuticals (Basel). 2023. PMID: 37111341 Free PMC article. Review.
References
- J Biol Chem. 1994 Jun 24;269(25):17075-9 - PubMed
- J Biol Chem. 1994 Jul 22;269(29):18881-90 - PubMed
- Blood. 1994 Aug 1;84(3):739-52 - PubMed
- Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10680-4 - PubMed
- Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11035-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials